Full Text View
Tabular View
No Study Results Posted
Related Studies
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops
This study has been completed.
Study NCT01087671   Information provided by Santen Oy

First Received on March 3, 2010.   Last Updated on November 18, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ocular Hypertension
Open-Angle Glaucoma
Additional conditions recognized in this trial
Glaucoma
Glaucoma, Open-Angle
Hypertension
Signs and Symptoms
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
tafluprost
Additional drug interventions recognized in this trial
Latanoprost
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Santen Oy


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services